Arcus Biosciences Inc (RCUS)
Return on assets (ROA)
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Net income | US$ in thousands | -307,000 | -267,000 | 53,000 | -123,000 | -84,710 |
| Total assets | US$ in thousands | 1,095,000 | 1,345,000 | 1,592,000 | 772,292 | 203,110 |
| ROA | -28.04% | -19.85% | 3.33% | -15.93% | -41.71% |
December 31, 2023 calculation
ROA = Net income ÷ Total assets
= $-307,000K ÷ $1,095,000K
= -28.04%
Arcus Biosciences Inc's return on assets (ROA) has fluctuated significantly over the past five years. The ROA was negative in four out of the five years, indicating that the company is not efficiently utilizing its assets to generate profits. The ROA of -28.04% in 2023 represents a significant decline from the previous year's -19.85%, reflecting worsening asset efficiency. The positive ROA of 3.32% in 2021 suggests a brief period of successful asset utilization, but this was followed by negative returns in subsequent years. The lowest ROA of -41.71% in 2019 indicates a particularly poor performance in that year. Overall, Arcus Biosciences Inc's ROA trend indicates a need for improved asset management strategies to enhance profitability.
Peer comparison
Dec 31, 2023